Sarcopenia in Cirrhosis: Fallout on Liver Transplantation

被引:43
|
作者
Kumar, Vaibhaw [1 ]
Benjamin, Jaya [2 ]
Shasthry, Varsha [2 ]
Bharathy, Kishore G. Subramanya [1 ]
Sinha, Piyush K. [1 ]
Kumar, Guresh [3 ]
Pamecha, Viniyendra [1 ]
机构
[1] Inst Liver & Biliary Sci, Dept Hepato Pancreato Biliary & Liver Transplant, New Delhi, India
[2] Inst Liver & Biliary Sci, Dept Clin Nutr, New Delhi, India
[3] Inst Liver & Biliary Sci, Dept Clin Res, New Delhi, India
关键词
nutritional status; asian indian; chronic liver disease; skeletal muscle area; liver transplant outcome; SKELETAL-MUSCLE MASS; WHOLE-BODY; IMPACT; OUTCOMES; COMPLICATIONS; SURVIVAL; COHORT; INDEX;
D O I
10.1016/j.jceh.2019.12.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Liver transplantation (LT) is a game changer in cirrhosis. Poor muscle mass defined as sarcopenia may potentially upset the LT scoreboard. Aim: To assess the prevalence and impact of sarcopenia on the intraoperative and early postoperative outcomes in Indian patients undergoing LT. Methods: Pre LT, single-slice routine computed tomography images at L3 vertebra of 115 LT recipients were analyzed, to obtain cross-sectional area of six skeletal muscles normalized for height in m(2) - skeletal muscle index (SMI; cm(2)/m(2)). SMI < 52.4 in males and <38.5 in females was called sarcopenia. The intraoperative, postoperative outcome parameters and 90-day mortality were compared between sarcopenics and nonsarcopenics. Results: Sarcopenia was found in 47.8% of patients [M (90.4%); age, 46.3 +/- 10; BMI, 24.5 +/- 4.3 kg/m2; child A:B:C = 1%:22%:77%; MELD, 20.6 +/- 6.3; etiology alcohol: nonalchohol = 53%:47%; Charlson Comorbidity Index (CCI) > 3:<= 3 = 56.5%:43.5%]. Sarcopenics vs. Nonsarcopenics; early postoperative complications: [sepsis, 49(89%) vs. 33(55%), P = 0.001; neurologic complications, 16(29.6%) vs. 5(8.8%), P = 0.040; Clavien-Dindo Classification 3-24 (43.6%):15 (25.4%),P = 0.041; ancillary parameters (days), duration of ventilation [median (range)] 1.5(1-3) vs. 1 (1-2), P = 0.021; intensive care unit (ICU) stay 12 (8-16) vs. 10 (8-12), P = 0.024; time to ambulation 9 (7-11) vs. 6 (5-7), P = 0.001; drain removal 18.7 +/- 7.3 vs. 14.4 +/- 6.2, P = 0.001; need for tracheostomy 5 (9%) vs. 0 (%), P = 0.017; preoperative prevalence of acute kidney injury, comorbidities and requirement for dialysis, intraoperative blood loss & inotropic support were significantly higher in sarcopenics. Ninety-day mortality was comparable between sarcopenics 5 (9.09%) and nonsarcopenics 4 (6.6%) P = 0.63. SMI (OR: 0.83; 95% CI: 0.71-0.97, P = 0.016; Acute on chronic liver failure (ACLF) presentation 12.5 (1.65-95.2), P = 0.015 and intraoperative blood loss 3.74 (0.96-14.6), P = 0.046 were predictors of 90-day mortality. Conclusion: Almost 50% of LT recipients had sarcopenia, who had a higher incidence of postoperative sepsis, neurological complications, longer ICU stay and ventilatory support. Low SMI, ACLF presentation, and intraoperative blood loss were the independent predictors of early mortality.
引用
收藏
页码:467 / 476
页数:10
相关论文
共 50 条
  • [31] Clinical characteristics of sarcopenia in patients with alcoholic liver cirrhosis
    Saeki, Chisato
    Kanai, Tomoya
    Nakano, Masanori
    Oikawa, Tsunekazu
    Torisu, Yuichi
    Saruta, Masayuki
    Tsubota, Akihito
    JGH OPEN, 2021, 5 (07): : 763 - 769
  • [32] Sarcopenia in patients with liver cirrhosis - a gender specific complication?
    Zimmerer, Thomas
    Hoertig, Thomas
    Antoni, Christoph
    Ebert, Matthias
    Nissen, Johanna C.
    HEPATOLOGY, 2014, 60 : 397A - 397A
  • [33] Assessment and prediction of malnutrition and sarcopenia in liver cirrhosis patients
    Sehgal, Pallavi
    Sharma, Sonika
    Sood, Ajit
    Dharni, Khushdeep
    Kakkar, Chandan
    Batta, Shaveta
    Sahotra, Mathew
    NUTRIRE, 2023, 48 (01)
  • [34] Clinical impact of sarcopenia assessment in patients with liver cirrhosis
    Marasco, Giovanni
    Dajti, Elton
    Ravaioli, Federico
    Brocchi, Stefano
    Rossini, Benedetta
    Alemanni, Luigina Vanessa
    Peta, Giuliano
    Bartalena, Laura
    Golfieri, Rita
    Festi, Davide
    Colecchia, Antonio
    Renzulli, Matteo
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 15 (04) : 377 - 388
  • [35] Sarcopenia in liver cirrhosis: perspectives from epigenetics and microbiota
    Xu, Jia-qi
    Pan, Yu-ke
    Zhang, Jie-xin
    Dai, Shi-xue
    Xu, Li-shu
    FRONTIERS IN MEDICINE, 2023, 10
  • [36] Sarcopenia in liver cirrhosis: Prevalence, pathophysiology and therapeutic strategies
    Fox, Rebecca
    Stenning, Kate
    Slee, Adrian
    Macnaughtan, Jane
    Davies, Nathan
    ANALYTICAL BIOCHEMISTRY, 2022, 647
  • [37] Bedside methods for the assessment of sarcopenia in patients with cirrhosis of liver
    Anand, Abhinav
    Gunjan, Deepak
    Singh, Namrata
    Madhusudan, K. S.
    Kaushal, Kanav
    Poudel, Shekhar
    Sharma, Sanchit
    Gopi, Srikanth
    Mohta, Srikant
    Agarwal, Samagra
    Chaman, Noor
    Grover, Indu
    Farooqui, Maryam
    Qamar, Sumaira
    Saraya, Anoop
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 519 - 519
  • [38] THE ASSOCIATION BETWEEN OSTEOPOROSIS AND SARCOPENIA IN ALCOHOLIC LIVER CIRRHOSIS
    Rogoveanu, I.
    Ionele, C.
    Florescu, D. N.
    Rogoveanu, O. C.
    Ungureanu, B.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S167 - S168
  • [39] Liver Cirrhosis: associating Frailty and Sarcopenia with poor Prognosis
    Franke, Katharina
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2018, 56 (01): : 10 - 10
  • [40] Effect of cirrhosis and liver transplantation
    Adigun, AQ
    Pinto, AG
    Flockhart, DA
    Gorski, JC
    Li, L
    Hall, SD
    Chalasani, N
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 95 (05): : 691 - 694